Search

Predicting diseases in the early stages is extremely important. By taking advantage of advances in deep learning and fuzzy logic techniques, a new model is proposed in this paper for disease evaluation depending on the adaptive neuro-fuzzy inference system (ANFIS) with a genetic algorithm (GA) for classification, and the pre-trained DenseNet-201 model for feature extraction, in addition to the whale optimization algorithm (WOA) for feature selection. Two medical databases (chest X-ray and MRI brain tumor) for the diagnosis of two disease types were used as input in the suggested model. The optimization of ANFIS parameters was performed by GA to achieve the optimum prediction capability. DenseNet-201 for feature extraction was employed to obtain better classification accuracy. Having more features sometimes leads to lower accuracy, and this issue can be rectified using a feature selection strategy WOA which gave good results. The proposed model was evaluated utilizing statistical metrics root mean square error (RMSE), mean square error (MSE), standard deviation (STD), and coefficient of determination ( R 2 ), and it was compared with the conventional ANFIS model, with the proposed model (ANFIS-GA) showing a superior prediction capability over the ANFIS model. As a result, it can be concluded that the proposed ANFIS-GA model is efficient and has the potential for a robust diseases evaluation with good accuracy. Also, we conclude from this work that integrating optimization algorithms with ANFIS boosts its performance, resulting in a more accurate and reliable model. [ABSTRACT FROM AUTHOR]

This paper discusses the problem of detecting cancer using such biomarkers as blood protein markers. The purpose of this research is to propose an approach for making decisions in the diagnosis of cancer through the creation of cost-sensitive SVM classifiers on the basis of datasets with a variety of features of different nature. Such datasets may include compositions of known features corresponding to blood protein markers and new features constructed using methods for calculating entropy and fractal dimensions, as well as using the UMAP algorithm. Based on these datasets, multiclass SVM classifiers were developed. They use cost-sensitive learning principles to overcome the class imbalance problem, which is typical for medical datasets. When implementing the UMAP algorithm, various variants of the loss function were considered. This was performed in order to select those that provide the formation of such new features that ultimately allow us to develop the best cost-sensitive SVM classifiers in terms of maximizing the mean value of the metric M a c r o F 1 − s c o r e . The experimental results proved the possibility of applying the UMAP algorithm, approximate entropy and, in addition, Higuchi and Katz fractal dimensions to construct new features using blood protein markers. It turned out that when working with the UMAP algorithm, the most promising is the application of a loss function on the basis of fuzzy cross-entropy, and the least promising is the application of a loss function on the basis of intuitionistic fuzzy cross-entropy. Augmentation of the original dataset with either features on the basis of the UMAP algorithm, features on the basis of the UMAP algorithm and approximate entropy, or features on the basis of approximate entropy provided the creation of the three best cost-sensitive SVM classifiers with mean values of the metric M a c r o F 1 − s c o r e increased by 5.359%, 5.245% and 4.675%, respectively, compared to the mean values of this metric in the case when only the original dataset was utilized for creating the base SVM classifier (without performing any manipulations to overcome the class imbalance problem, and also without introducing new features). [ABSTRACT FROM AUTHOR]